CONNECT BIOPHARM: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in CONNECT BIOPHARM. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
4
13F filers
Aggregate Value
$1.6M
Across holders
Last Price
—
EOD close
Sector
—
GICS
Quarterly fund activity2 increased2 reduced2 exited
Full exits: Point72 Asset Management, L.P., CITADEL ADVISORS LLC
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 336K | $799K | 50.4% | 0.0% | Added | +$760K | Q2 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 199K | $475K | 29.9% | 0.0% | Added | +$362K | Q2 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 87K | $208K | 13.1% | 0.0% | Reduced | $-79K | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 44K | $104K | 6.6% | 0.0% | Reduced | $-1.0M | Q2 2026 |
Added
Hedge Fund
$799K· 50.4% of total· 0.0% port· 336K sh· +$760K QoQ· Q2 2026
Added
Hedge Fund
$475K· 29.9% of total· 0.0% port· 199K sh· +$362K QoQ· Q2 2026
Reduced
Hedge Fund
$208K· 13.1% of total· 0.0% port· 87K sh· $-79K QoQ· Q2 2026
Reduced
Hedge Fund
$104K· 6.6% of total· 0.0% port· 44K sh· $-1.0M QoQ· Q2 2026